Effects of Caffeic Acid on Serum Lipid Profile and Atherogenic Index in Alloxan-Induced Diabetic Rats
Background and Aim: Diabetes is a major public health problem worldwide. Oxidative stress is a risk factor in diabetes. The aim of this study is to evaluate the possible beneficial effect of caffeic acid (CA) on serum lipid parameters and atherogenic index in alloxan-induced male diabetic rats. Mat...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Lorestan University of Medical Sciences
2017-03-01
|
Series: | Herbal Medicines Journal |
Online Access: | http://hmj.lums.ac.ir/index.php/hmj/article/view/591 |
Summary: | Background and Aim: Diabetes is a major public health problem worldwide. Oxidative stress is a risk factor in diabetes. The aim of this study is to evaluate the possible beneficial effect of caffeic acid (CA) on serum lipid parameters and atherogenic index in alloxan-induced male diabetic rats.
Materials and Methods: 40 male Wistar rats were randomly divided into 4 groups: group I as the healthy control group, group II as the healthy group treated with CA (50 mg/kg i.p. daily), group III as the diabetic control group and group IV as the diabetic group treated with CA (50 mg/kg i.p.daily). Diabetes was induced in the 3rd and 4th groups by the injection of alloxan monohydrate (100 mg/kg s.c). After seven weeks, animals were anaesthetized and blood samples were collected. Then, the serum level of fasting blood glucose (FBS), lipid parameters and the atherogenic index were measured.
Results: The serum level of FBS, cholesterol, low density lipoprotein (LDL-C) and atherogenic index significantly decreased in the diabetic group treated with CA compared with the untreated diabetic group. The serum level of high density lipoprotein (HDL-C) significantly increased in the treated diabetic group compared with the untreated diabetic group.
Conclusion: The results of this study indicated that CA has beneficial effects on serum blood glucose, lipid profile and atherogenic index in type 1 diabetic rats. |
---|---|
ISSN: | 2538-2144 2538-2144 |